It is generally accepted that the conversion of substrate should be kept at less than 10% of the total substrate used when studying enzyme kinetics. However, 10% or less substrate conversion often will not produce sufficient signal changes required for robust high-throughput screening (HTS). To increase the signal-to-background ratio, HTS is often performed at higher than 10% substrate conversion. Because the consequences of high substrate conversion are poorly understood, the screening results are sometimes questioned by enzymologists. The quality of an assay is judged by the ability to detect an inhibitor under HTS conditions, which depends on the robustness of the primary detection signal (Z factor) and the sensitivity to an inhibitor. The assay sensitivity to an inhibitor is reflected in the observed IC 50 value or percent inhibition at a fixed compound concentration when single-point data are collected. The major concern for an enzymatic assay under high substrate conversion is that the sensitivity of the screen may be compromised. Here we derive the relationship between the IC 50 value for a given inhibitor and the percentage of substrate conversion using a first-order kinetic model under conditions that obey Henri-Michaelis-Menten kinetics. The derived theory was further verified experimentally with a cAMP-dependent protein kinase. This model provides guidance for assay developers to choose an appropriate substrate conversion in designing an enzymatic assay, balancing the needs for robust signal and sensitivity to inhibitors. (Journal of Biomolecular Screening 2003:694-700) 
INTRODUCTION
R ECENT STUDIES SHOWED that 47% of all the marketed smallmolecule drugs act on enzymes. 1 Because enzymes are such important drug targets, it is not a surprise that a large portion of high-throughput screening (HTS) has been performed with enzymes. [2] [3] [4] There has been a wealth of knowledge about enzyme kinetics since 1902 when Henri derived what is now most frequently cited as the Michaelis-Menten equation. [5] [6] [7] Both rapid equilibrium analysis and steady-state analysis of enzyme kinetic studies were based on unisubstrate enzyme systems. A multisubstrate enzyme system, such as kinases that use a protein/peptide and ATP as substrates, can be experimentally manipulated so that the substrate to be studied is set at a concentration that is much lower than the other substrates to obtain a pseudo-uni-substrate system. 8 This pseudouni-substrate system allows the application of theory derived from unisubstrate systems. In HTS for enzyme inhibitors, tens of thou-sands to millions of compounds at a fixed concentration are assayed with substrate and enzyme at fixed concentrations under identical assay conditions. In a typical HTS operation, only 1 data point in the reaction course instead of the whole reaction progression curve is measured to reduce the cost. In contrast, enzymologists dealing with a few compounds usually measure the whole reaction progression curve to obtain the initial velocity when no substrate has been depleted due to its conversion to products.
It is a general rule that an assay should be designed to give a measured velocity as close to initial velocity as possible if only 1 point in the reaction progression curve is measured. For a simple first-order reaction converting substrate to product, single-point measurement at 10% substrate conversion would give a velocity that is 5% lower than the true velocity. Thus, staying at or below 10% turnover will provide results close to the true initial velocity. In many assay formats, 10% or lower substrate conversion will not produce sufficient signal changes to be detected. Examples of these assays are mobility shift assays such as the kinase assay employing Caliper microfluidic systems where the substrate and product fluoresce at similar intensity, fluorescence polarization assays where substrate is fluorescently labeled and the product selectively binds to large polymeric acceptors or beads, and kinase assays wherein the change in ATP concentration is detected by luminescence using luciferase and luciferin. To increase the pri-mary detection signal-to-background ratio (and hence the Z factor 9 ), assay designers often ignore the 10% rule and perform the assay at higher substrate conversion. 10 The benefit of increased substrate conversion can be appreciated in a hypothetical scenario as shown in Table 1 . However, the merits of this practice are often questioned by some enzymologists when the screening results are in question. Because of the lack of theoretical analysis of what consequences will occur when substrate conversion is higher than 10%, and our frequent use of high substrate conversion when using the microfluidic screening methods, we derived equations that reveal the relationship between the single time point measured IC 50 values and the substrate conversion based on the first-order substrate depletion reaction progression curve. Because an enzymecatalyzed unisubstrate reaction that obeys the Henri-Michaelis-Menten equation will suffer the most substrate depletion under first-order substrate depletion kinetics, our equation reveals the maximum IC 50 changes at specific substrate conversion relative to the IC 50 value at no substrate conversion.
MATERIALS AND METHODS

Materials
The catalytic subunit of cAMP-dependent protein kinase (PKA) was obtained from Promega (Madison, WI). The fluorescently labeled kemptide substrate for PKA, 5-FAM-LRRASLG-CONH2, was custom synthesized by Synpep (Dublin, CA). Protein kinase A inhibitor 5-24 (PKI) was purchased from Calbiochem (San Diego, CA). Other chemicals were purchased from Sigma (St. Louis, MO). Final reaction buffer contains 100 mM HEPES, pH 7.5, 5 mM MgCl 2 , 0.01% Triton X-100, 1 mM DTT, 10 µM ATP. Termination solution contains 200 mM EDTA and 2% coating polymer-3 (Caliper Technologies Corp., Mountain View, CA) in water.
Methods
The activity of PKA is measured by the phosphorylation of a substrate, 5-FAM-LRRASLG-CONH2. A Caliper 100 instrument (Caliper Technologies Corp., Mountain View, CA) together with the Caliper SP216 chip was used to measure the phosphorylation process. Figure 1 shows schematically the operation of the Caliper off-chip kinase assay. In this assay format, kinase and fluorescently labeled substrate are mixed in a well in a microplate for a predetermined time to generate the product that is the fluorescently labeled substrate with 1 or more phosphate groups added to the peptide. Each addition of phosphate group will increase the negative charge of the peptide by 2 units. The reaction mixture of the product and substrate in each well are introduced to the chip through a sipper. Due to the charge difference, the product and substrate are separated on the chip in the flow path in a voltage gradient. The fluorescence signal is detected at a fixed distance down the separation channel. The peak heights of the product and substrate in each well are measured. The percent conversion is calculated by dividing the product peak height by the sum of the substrate and product peak height.
The inhibition of PKA activity by PKI was used to test the proposed model. Different concentration of PKI in 1 µl was added to a 96-well microplate so that each row contained the same amount of PKI but each column contained different amount of PKI. To the whole plate, 50 µl 0.4 nM PKA in reaction buffer was then added at the same concentration. After 10-min incubation, 50 µl 2 µM substrate in buffer was added to one column at a time to start the reaction. After a predetermined time interval, another 50 µl of substrate was added to the next column to a start a new reaction. This proce- We assume an assay with 6% coefficient of variation (CV) in the measurement of all the signals. We further assume the assay has a background (B) of 100 counts and a signal (S) of 150 counts (100 counts from the background and 50 counts from the product) at 10% substrate conversion. This assay has a Z factor of 0.1 that is unacceptable for screening. If we increase the substrate conversion by a factor of 5, the signal (S) will increase to 350 counts (100 counts from background and 250 counts from the 5-fold increased product). With the 5-fold increase in substrate conversion, the Z factor of this assay increased from 0.1 to 0.676. dure was repeated until the 12th column. The final reaction mixture in each well contained 0.2 nM PKA, 1 µM substrate, 10 µM ATP, and 5 mM MgCl 2 . The final PKI concentration from different columns was in the range from 0 to 32 nM. To terminate the reaction, 10 µl termination solution was added to all the wells on the plate. The final solution contained about 20 mM EDTA and 0.2% coating polymer-3, which was used to maintain a consistent surface on the microchip channel over time so that a constant flow rate and constant separation of substrate and product was maintained throughout the assay. The reaction mixture in each well on the plate was introduced through the sipper to the Caliper SP216 chip. The product and substrate were separated on the chip, and the fluorescence signal for product and substrate were measured.
RESULTS
Theoretical analysis
We used the following enzyme-catalyzed unisubstrate (S) conversion to product (P) as a model for the analysis:
When designing an assay, enzyme concentration is usually kept as low as possible so that it is most sensitive to inhibitors. It is common that [E] << [S] and the velocity of the reaction is given by
where [ES] is the enzyme substrate complex concentration and K m is the Henri-Michaelis-Menten constant. The following conclusion can be made according to this equation. When [S] >> K m , the reaction proceeds at zero order, and the reaction velocity will remain the same irrespective of the substrate conversion. When [S] << K m , the reaction proceeds at first order, and the velocity of the reaction will decrease with the increase of substrate conversion. Between these 2 extreme situations, the reaction proceeds with a reaction progression curve between first order and zero order. Thus, the largest deviation of the measured velocity at high substrate conversion from the true velocity is when the reaction proceeds with first-order kinetics ([S] << K m ). It is important to derive the relationship between the IC 50 measured at a specific substrate conversion and the IC 50 measured with initial velocity under firstorder kinetics conditions. An assay with a reaction progression curve following first-order kinetics is shown in Figure 2 . The product generated at time t is governed by equation (2) 7 :
where [P] ∞ is the product generated at infinite time, which is equal to the starting substrate concentration for irreversible reactions, x is the percent of substrate conversion, and k is the reaction rate constant. Kinetically, the net effect of a normal enzyme inhibitor is to reduce the reaction rate constant k to a different extent depending on the concentration of the inhibitor used and its intrinsic affinity to the enzyme (K i ). Experimentally, the IC 50 value is an apparent measure of the potency of an inhibitor at specific experimental conditions. Figure 2 shows the reaction progression curve for the production of the product in the presence and absence of inhibition simulated by equation (2).
With no substrate depletion (true initial velocity measurement) and in the absence of an inhibitor, the true reaction rate constant k 0 can be obtained by fitting the reaction progression curve to equation (2) . In the presence of an inhibitor, the true reaction rate constant k can be obtained the same way. The reaction rate constant k in the presence of inhibition will be lower than k 0 . The percent inhibition is defined as percent reduction of the reaction rate constant (k) as compared with the rate constant in the absence of an inhibitor (k 0 ). Thus, %Activity is commonly defined as k/k 0 and %Inhibition is 1 -%Activity. With an inhibitor that has 1 binding site on an enzyme, the IC 50 value of the inhibitor is defined by equation (3):
where [I] is the concentration of the inhibitor. 
Illustration of the deviation of measured velocity from true initial velocity at different conversion level. Simulated reaction progression curves in the absence of inhibitor and at 2 different inhibition levels are shown as the curved lines. The true rate constants obtained from initial velocity measurement are represented as the slope of the solid lines, which are labeled as k 0 (in the absence of inhibitor), k 1 (65% inhibition), and k 2 (94% inhibition). k 0 , k 1 , and k 2 can be obtained by measuring the reaction progression curve and then fitting the curve to equation (2). With singlepoint measurement at time t = 2 when significant substrate depletion occurs, the measured rate constants are represented by the slope of the dashed lines, which are labeled as k 0 ′ (in the absence of inhibitor), k 1 ′ (65% inhibition), and k 2 ′ (94% inhibition).
Experimentally, especially in HTS operations, a reaction progression curve is not measured. Instead, single-point measurement of final product concentration at time t is obtained with fixed substrate and enzyme concentrations and with varying inhibitor concentration (see Fig. 2 ). The percent enzyme activity in this case is defined as %Activity = [P]/[P] 0 , where [P] 0 is the product concentration at time t in the absence of inhibitor.
[P] ∞ is a constant value at any inhibition level if we assume all substrate will eventually be converted to product if enzymes remain active. Thus, with singlepoint measurement at time t, the IC 50 ′ value is expressed as
where k′ is the measured rate constant at time t in the presence of an inhibitor and k 0 ′ is the measured rate constant at time t in the absence of an inhibitor. We used the prime (′) sign to distinguish the values obtained in single-point measurement from the corresponding values obtained in true initial velocity measurement. Because of substrate depletion, the single-point measured rate constant k′ and k 0 ′ will be less than the true initial rate constant k and k 0 , respectively. The extent of the deviation depends on the reaction progression curve. With the first-order substrate depletion model shown in Figure 2 , a single-point measurement of rate constant k′ at a specific time at which substrate conversion is 10% will be 5% less than the true initial rate constant k. This small deviation is acceptable for normal enzyme kinetic studies. Thus, as a rule of thumb, reaction rate constant can be measured at less than 10% substrate conversion. At substrate conversion of more than 10%, the measured reaction rate constant will be further reduced. This may not be an acceptable situation for serious kinetic studies to obtain k cat or K m values. For HTS, however, the requirements for robust signal and sensitivity to potential inhibitors are more important than the determination of accurate kinetic parameters. Due to the reduction of the measured reaction rate constant at high substrate conversion, the IC 50 ′ value using single-point measurement should be different from the IC 50 value measured by true initial velocity when no substrate conversion has occurred. Below, we quantitatively analyze the difference between IC 50 and IC 50 ′ at different substrate conversion based on the first-order reaction progression curve.
From equation (2), time t can be replaced by percent conversion x in the absence of an inhibitor, as shown in equation (5) .
Thus, the single-point measured rate constant in the absence of inhibition is given by equation (6).
At this time point t, the single-point measured rate constant k′ in the presence of an inhibitor with a true initial rate constant of k can be derived from equation (2) and equation (5) as shown in equation (7) . 
Combining equations (6) and (7), we obtain equation (8) . 
Combining equations (4) and (8), we obtain equation (9). 
From equation (3), we know that when [I] = IC 50 , k/k 0 = 0.5. Substituting these conditions into equation (9), we obtain equation (10). 
From equation (10), we obtain equation (11), which gives the relationship between an inhibitor's IC 50 and substrate conversion at a given assay condition.
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where IC 50 is the inhibitor concentration at which 50% of inhibition is observed when the inhibition is measured by initial velocity when there is no substrate conversion. Equation (11) clearly demonstrates the relationship between the single-point measured IC 50 ′ value and the percent substrate conversion (in the absence of an inhibitor) under the assay conditions. This relationship is based on the assumption that the substrate depletion follows first-order kinetics. Equation (11) can be graphically represented as shown in Figure 3 . When keeping the substrate conversion at less than 10%, the single-point measured IC 50 ′ value is expected to be shifted only to 1.05 × IC 50 , which is close enough to the true IC 50 value for theoretical studies. At 50% substrate conversion, the IC 50 ′ value is expected to be shifted to 1.4 × IC 50 . From equation (4), we can transform the effect of IC 50 change to the percent inhibition change for an inhibitor that gives 50% inhibition when initial velocity is used. The results are summarized in Table 2 . At low substrate conversion, the measured percent inhibition becomes lower gradually as the substrate conversion increases. At higher than 80% substrate conversion, the IC 50 ′ Substrate Conversion for Enzymatic Assays significantly deviates from the true IC 50 value, and the percent inhibition for a 50% inhibitor will be reduced to less than 31%. In this case, care must be taken to balance the needs of robust signal with the reduced screening sensitivity.
Testing the theoretical model with PKA
The above model is developed based on an enzyme reaction that has a progression curve following first-order kinetics. With enzyme reactions that have substrate concentration less than the K m , the reaction progression curve should be close to first-order kinetics (see the Discussion section). Inhibition of PKA by PKI using 5′-FAM-kemptide as a substrate at a concentration less than its K m was used as an example to examine the above analysis. The assay was performed at substrate concentration of 1 µM, less than its K m of~10 µM. The ATP concentration was set at 10 µM, which is 10 times higher than the substrate concentration, to obtain a pseudo-first-order reaction condition. The K m for ATP is~3 µM. The phosphorylation at different PKI concentrations and different times was measured and plotted as shown in Figure 4 . The 12 data points at different reaction times and at 8 different PKI concentrations were fit to equation (2) to obtain the reaction progression curve.
To obtain the IC 50 values of PKI at different substrate conversion, the 8 fitted reaction progression curves at different PKI concentrations obtained in Figure 4 were used to calculate the product generated at different substrate conversion. This set of data is plotted in Figure 5 . The data were fitted to equation (4) to obtain the respective IC 50 ′ values at different substrate conversion. The IC 50 value for PKI at no substrate conversion was obtained by fitting the reaction rate constant at different PKI concentrations to equation (4) . This result is shown in Figure 6 . The IC 50 value was 0.81 ± 0.06 nM. The results obtained from Figures 5 and 6 are summarized in Table 3 . The experimental results for PKI inhibition of PKA agreed very well with the results derived from equation (11) .
DISCUSSION
The analysis is based on the commonly used first-order substrate depletion model with no requirement for any particular k cat or K m for the enzyme and substrate. The model is universal for any enzyme-catalyzed reaction as long as the substrate to be monitored depletes according to first-order kinetics and the inhibitor does not change the final product and substrate equilibrium. The model can be applied to multisubstrate enzymes as well, such as kinases that use ATP and a protein/peptide as substrates. The only requirement is that the concentration of the substrate to be measured should be at least a factor of 10 lower than the other substrate involved so that there is no depletion of other substrate(s). The inhibition of PKA by PKI demonstrates that the current model fits the experiment very well.
Although a first-order kinetic model has been commonly used to describe an enzyme-catalyzed reaction progression curve, there FIG. 3. Graphical representation of the relationship between singlepoint measured IC 50 ′ value and the percent of substrate conversion. This graph is based on equation (11) . The IC 50 is the inhibitor concentration at which 50% of reduction in rate constant is observed when the rate constant is measured by initial velocity with no substrate conversion to product. The inserted table lists theoretical IC 50 values at different substrate conversions. are situations in which the reaction progression curve does not follow first-order kinetics. From equation (1) the reaction follows first-order kinetics. This is exactly the case we analyzed when equation (11) was derived, and it represents the case in which the IC 50 ′ is most sensitive to substrate conversion. When substrate concentration is between the 2 extreme cases, the reaction progression curve transitions from first-order to zeroorder kinetics. No simple relationship between IC 50 ′ and IC 50 can be derived for this transition. Numerical approaches can be used to correlate IC 50 ′ and IC 50 using our proposed method of analysis by substituting equation (2) with equation (1) . However, because we know that the situation we analyzed is the most sensitive case for IC 50 changes, the measured IC 50 at a particular substrate conversion in such cases will deviate less. The higher [S]/K m , the more the reaction shifts from first order toward zero order and the smaller the deviation in the IC 50 value. Thus, we can conclude that the IC 50 ′ value measured at 50% substrate conversion will be always equal or less than 1.4 × IC 50 , and a compound that should give 50% inhibition will inhibit by a minimum of 41% in any case. This deviation caused by 50% substrate conversion should be acceptable in HTS operations if it is in line with the overall assay variability. The current model also showed that excessive substrate conversion should be avoided. As shown in Figure 3 , the measured IC 50 ′ values deviate gradually from the true value at low substrate conversion and deviate significantly from the true value at excessive substrate conversion.
The importance of the current analysis is that it deals with the first-order kinetic model that is encountered most frequently in an enzyme assay. The selection of the substrate concentration for screening is determined by the sensitivity of the assay to an inhibitor. There are 3 basic kinds of inhibitors: 1) competitive inhibitors that compete with substrate for the binding site, 2) noncompetitive inhibitors that bind to the enzyme independent of the substrate, and 3) uncompetitive inhibitors that bind only to substrate-bound enzymes. The lower the measured IC 50 for an inhibitor, the more sensitive the assay is. The IC 50 values of competitive and uncompetitive inhibitors at specific substrate concentrations are derived by Cheng Figure 4 , the product generated (in terms of percent substrate conversion) at 8 specific PKI concentrations was calculated at different levels of substrate conversion in the absence of inhibition. The data for each conversion level were then fitted into equation (4) to obtain the IC 50 ′ values at different substrate conversion levels. The results are summarized in Table 2 . Figure 4 , the reaction rate constant k was obtained by fitting the data to equation (2) at 8 specific PKI concentrations. The data were then fit into equation (3) to obtain the IC 50 value. The IC 50 value for PKI at initial velocity when there is no substrate conversion was obtained from Figure 6 . The IC 50 ′/IC 50 ratio was calculated and compared with the IC 50 ′/IC 50 predicted by equation (11 Thus, lowering the substrate concentration will lower the IC 50 value of a competitive inhibitor and thus make the assay more sensitive to the competitive inhibitor. However, an uncompetitive inhibitor binds only to substrate-bound enzyme, and thus a lower concentration of substrate will make the assay less sensitive to uncompetitive inhibitors. By definition, a noncompetitive inhibitor is not affected by substrate concentration. To balance all 3 cases, substrate concentration at K m is often used for screening all potential inhibitors. 10 In practice, scientists are usually more interested in competitive inhibitors, and thus the substrate concentration is more often set at below K m and the first-order reaction progression curve is therefore most often encountered. The current analysis provides an important tool for this situation. This study offers quantitative guidance for choosing the appropriate level of conversion in developing assays for HTS.
Because of the assumptions used in deriving the current equations, care must be taken in making applications. First, we assumed that the reverse reaction is negligible. This is true for many enzyme-catalyzed reactions. For enzymes that use 2 substrates, the assay usually has 1 substrate at more than 10 times the concentration of the other. In this situation, the reaction favors complete conversion of the less-concentrated substrate to product. This is demonstrated in the PKA assay. For a protease assay that uses a single peptide substrate, peptide bond breaking is frequently a thermodynamically favored process, and the reaction usually proceeds close to completion as well. We have observed that caspase-catalyzed amide bond breaking proceeds to more than 90% completion (unpublished results). When studying enzyme-catalyzed reactions that have significant reverse reaction, the current treatment should still be valid as long as the inhibitor does not change the final equilibrium between substrate and product at any inhibition level. However, the substrate conversion (x) should be redefined for this case. Second, some inhibitors show complicated inhibition patterns, making standard kinetic models inadequate. One example is the inhibition of caspase-1 by aryloxymethyl and acyloxymethyl ketones that show bimodal inhibition. 12 The reaction progression curve starts with reversible inhibition that is followed by slower irreversible inhibition. We have observed similar results when studying the inhibition of caspase-3 by the known inhibitor Ac-DEVD-CHO (unpublished results). The current equation is not applicable here because both the reaction rate constant (k) and the final product concentration ([P] ∞ ) change at different inhibition levels. In this case, high substrate conversion actually decreases the IC 50 values for the inhibitor compared with less than 10% substrate conversion. Thus, an assay with high substrate conversion should be favored because both the primary assay signal and the assay sensitivity for an inhibitor will increase with increasing substrate conversion.
The results of the present study can guide both primary screen design and follow-up IC 50 studies when the system to be studied meets the stated criteria. For example, in typical primary screens with compound screening concentration at 10 µM, 50% substrate conversion will have little effect on the ability to detect weak inhibitors with IC 50 close to 10 µM if the hit identification criterion is set at >50% inhibition. However, if substrate conversion is at 90%, the same inhibitor's apparent IC 50 ′ would change to 30 µM, and this inhibitor would not be picked as a hit. For IC 50 studies, to get robust signal, almost any substrate turnover (<90%) can be used as long as the conversion is known and the reaction progression curve has been demonstrated to follow first-order kinetics. The true IC 50 value can then be calculated from the measured IC 50 ′ value using equation (11) .
